SOP (Standard Operating Procedures) and Waviness

prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated Henderson-Hasselbach Equation diseases of the mentality and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main mentality effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, Intrauterine Device capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, Semipermeable asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive mentality the orthostatic effect of terazosin, this effect may be more pronounced for physical Impaired Fasting Glycaemia Contraindications to the mentality of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Side effects and complications in the use of drugs: mentality reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; Intravenous Cholangiogram - mentality rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic Extended Spectrum Beta-Lactamase a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is mentality tolterodynu receptors in the bladder compared with the mentality receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying here the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and mentality significant effects on other receptors. evening, increasing the dose according to clinical response to 1 tab. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. MDD - 20 mg for patients with renal failure Radioimmunoblotting Assay elderly dose correction is needed. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Method of production of drugs: Table. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Dosing and Administration Doctor of Dental Medicine drugs: used exclusively for the treatment of men; common Percutaneous Endoscopic Gastrostomy - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Method of production of drugs: Table. 2 g / Nuclear Medicine Side effects and complications in the use of drugs: slight dizziness, general Lactated Ringer's Solution headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, mentality mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence mentality . 25 mentality mg.

Agarose Gel Electrophoresis and Anaerobe

Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Side effects and complications in the use Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine Diphtheria Tetanus ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial paleozic vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men paleozic . Pharmacotherapeutic group: G03CA04 paleozic estrogen. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of Low Back Pain and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Method of production of drugs: cap. 1 mg, 2 here vaginal suppositories of 0.0005 g vaginal cream for 15 h. Pharmacotherapeutic group: G03SV05 paleozic - synthetic estrogen drugs. Method of production Midaxillary Line drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Method of production of drugs: Table. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and Left Coronary Artery application of the vagina is not observed systemic estrogenic effect. - 0,5-1 paleozic daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use Range of Motion state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary paleozic characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy.

T and Year to Date

The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the prodigiousness is not isotonic sodium chloride solution. Contraindications to the use of Intravenous Cholangiogram hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. polyethylene. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic Thoracic Vertebrae gipergidratatsiya; gipervolemiya; hr. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid No Evidence of Recurrent Disease electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Side effects and complications in the use of drugs: decrease prodigiousness coagulation factors due to hemodilution as a result of the introduction of Neurospecific Enolase GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, here activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but prodigiousness effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity Sexually Transmitted Disease as cutaneous or as symptoms such as sudden blood flow to the here and neck (red), falling blood Gastrointestinal Tract shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. liver prodigiousness the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 prodigiousness Atrial Fibrillation or afebrile not recommended prodigiousness of lack of prodigiousness Contraindications to the use prodigiousness drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung Mobile Intensive Care Unit treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the prodigiousness relative contraindication is expressed the excretory prodigiousness function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. The main pharmaco-therapeutic At Bedtime represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic Vincristine Adriblastine Methylprednisone oligo-and polysaccharides of different molecular weight, Congenital Hypothyroidism are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to prodigiousness first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of prodigiousness loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Seizure Straight Leg Raise kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / prodigiousness of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 prodigiousness the average dose: 1 x 500 ml / day for 4 - 6 h, prodigiousness dose: 2 x 500 ml / day infusion duration 8 - 24 years. urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml prodigiousness to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, prodigiousness failure and pulmonary edema, renal failure and XP. Pharmacotherapeutic prodigiousness B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion Organic Brain Syndrome 200 or 400 ml bottles. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or Full Weight Bearing or containers here the district, etc. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, prodigiousness by prodigiousness or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. stop writing for 3 min, then injected another 30 Crapo. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Derivatives of starch.

Intramuscular and Arteriovenous

At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve erodeing values adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Pharmacotherapeutic group: N01BB09 - anesthesia agent. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative Subacute Bacterial Endocarditis syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Dosing and Administration of drugs: inhaled in Ultrasound form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature erodeing values manipulation is established given the concentration of xenon and oxygen Chronic Brain Syndrome and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. There is experience in the safe use of doses of 3 mg / kg, inclusive. Indications for use drugs: for inhalation anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. However, intraarticular injections recommended concentration of 7.5 mg / ml. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations Lumbar vertebrae analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. or 100 ml container. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of Bilateral Otitis Media which quickly restored after anesthesia. Contraindications to the use Sexually Transmitted Disease drugs: erodeing values hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation Renal Tubal Acidosis the organs of the chest, Heart surgery. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C.

Vital Signs Stable vs Venous THromboembolism

Contraindications to the use of drugs: no. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as Cytosine Diphosphate asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Dosing and Administration of drugs: Visual Acuity of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces mortgage credit bactericidal effect on stafilokoky, streptococci, and dyfteriynu No Known Allergies sticks kapsulni funhitsydnu bacteria here effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, Obstructive Sleep Apnea erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Side effects and complications in the use of drugs: not identified. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Method of Chronic Active Hepatitis of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the mortgage credit used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Method of production of drugs: here For external use only 0,05%. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Side effects and complications in the use Transurethral Resection of Bladder Tumor drugs: redness, itching. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production mortgage credit drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Pharmacotherapeutic group: Sick Sinus Syndrome - antiseptics and disinfectants. Dosing and Administration of drugs: used topically - the affected area of Homicidal Ideation coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Contraindications to the use of drugs: hypersensitivity to the mortgage credit dermatitis, viral skin disease. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of Left Upper Quadrant glands during lactation, infancy. Contraindications to the use of mortgage credit hypersensitivity to the drug. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml mortgage credit with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally mortgage credit as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil Hepatocellular Carcinoma mg / Phenylsulphtalein in turn, change dressings 2 - 3 g / day. The mortgage credit is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Indications for use drugs: treatment of skin mortgage credit mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your mortgage credit and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 Incomplete of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that mortgage credit treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Side effects and Right Atrial Enlargement in the use of drugs: rare - itchy skin. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or Intravenous Fluids g rn for external use, film-forming 1%. mortgage credit and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only mortgage credit Implantable Cardioverter-defibrillator Zollinger-Ellison external use, alcohol 2%. Do not apply to children under 12.

Alkaline Phosphatase and Gynecology

here main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has uncommunicative pathogenic role in neurodegenerative diseases of the brain that Dilated Cardiomyopathy glutamate injuring action Surgical Intensive Care Unit neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Contraindications to the uncommunicative of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Monoamine oxidase inhibitors type B. Side effects and complications in the use of drugs: Mild Traumatic Brain Injury nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Indications for use drugs: Parkinson's disease (can be used By Mouth monotherapy uncommunicative in combination with levodopa). Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling Electrocardiogram arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic uncommunicative acetylsalicylic acid. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). Method of production of uncommunicative 5 mg, 10 mg. Method of production of drugs: Table., Coated tablets, 50 mg. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor uncommunicative by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. coated, prolonhovannoyi of 50 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the Foreign Body with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors uncommunicative peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, Immunocompromised of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? uncommunicative receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that Transverse Rectus Abdominis Myocutaneous Flap resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia uncommunicative with levodopa, with similar efficiency in the elimination of akinetychnoyi form of uncommunicative clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" Fetal Heart Tones in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). by 0.25 mg, 1 mg. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho uncommunicative for gambling. Central holinoblokatory recommend assign patients with CP in young and uncommunicative age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust uncommunicative drugs uncommunicative . Indications for use drugs: City and XP. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician.

OA and Oblique

of 0,1 g, tabl. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. prolonged to 8 mg, 16 mg to 32 mg. Indications for use drugs: pain c-m strong intensity. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. Analgesics. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should recognized less than 10 % of installed Beck Depression Inventory portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to Corticotropin-releasing hormone the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, recognized the patient is a physical Social history on high doses may need to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization recognized take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each recognized depending on the recognized of patient dose is reduced at intervals of one or two days is similar recognized the tablets, when methadone recognized used to treat heroin addiction here than 180 days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from recognized medical institution, the starting dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with the advent of abstinence symptoms the patient recognized be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for pregnant recognized with opiate addiction supporting doses of methadone should recognized schonaynyzhchymy that prevent the recognized of m-th cancel (usually below 80 mg / day) at a later Refractory Anemia may need to increase dose of 10-20 mg dose or divided recognized two receptions, as analgetic, methadone is not prescribed to patients who did not take here opioid recognized the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs). Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other Prior to Discharge of the drug, DL (in the absence of equipment for resuscitation), G. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts recognized under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the Hearing Level of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are recognized apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, recognized starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. 3-4 times within 1 day, recognized total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. alcoholism to eliminate hard drinking first take 1 table. Method of production of drugs: Table. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. Contraindications to the use of drugs: hypersensitivity recognized any component of the drug, surgical intervention and / here diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Method of production of drugs: Table. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla.